Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle ...

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of ...

Swelling of the ankles, known as oedema, is linked to fluid accumulation and is cited by the NHS as a primary indicator of ...

Patients and families need to know how these extraordinary treatments might change how they feel about themselves and the ...

The BiVACOR Total Artificial Heart (TAH) has a single moving part: a levitated rotor held in place by magnets. As the name ...

The titanium device’s underlying principles were first envisioned in 2001 by a biomedical engineer named Daniel Timms. Timms, ...

The symptoms of heart failure can differ among individuals and may appear suddenly or 'develop gradually' over weeks or even months. Other warning signs to be aware of include: Breathlessness. This ...

The implant is designed to sustain patients until a donor heart is available, but BiVACOR’s long-term goal is to enable recipients to live indefinitely with the device without needing a transplant.

A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

Doctors and dietitians with the Physicians Committee for Responsible Medicine are sharing their concerns about the health ...

A man in Australia becomes the first to survive 100 days with a titanium artificial heart before receiving a transplant.